PLYX
Polaryx Therapeutics, Inc. Common Stock
NASDAQ: PLYX · HEALTHCARE · BIOTECHNOLOGY
$5.22
-7.28% today
Updated 2026-04-29
Market cap
$247.13M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.19
Dividend yield
—
52W range
$2 – $49
Volume
1.1M
Polaryx Therapeutics, Inc. Common Stock (PLYX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 1
Last 1 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+13.8%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+13.8%
2026-03-24
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-24 | $-0.16 | -700.0% | $5.52 | $6.28 | +13.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.02 | $-0.16 | -700.0% | — | — |
Frequently asked questions
Has Polaryx Therapeutics, Inc. Common Stock beaten earnings estimates?
Polaryx Therapeutics, Inc. Common Stock has beaten Wall Street EPS estimates in 0 of its last 1 quarterly reports.
How does PLYX stock react to earnings?
PLYX stock has moved an average of +13.8% in the trading day following earnings over its last 1 reports, with positive reactions in 100% of those quarters.